Bastion Therapeutics’ Post

📢 New Online special issue: Immuno-Materials: at the interdisciplinary of immunology and materials is open for submissions now!! Welcome join us and discuss this topic! 📰 Edited by Dr. Wantong Song 🎯 A fundamental basis underlying immuno-materials is the understanding the basic process of how the immune cells recognize the pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) through the pattern recognition receptors (PRRs), and thus developing materials with patterned structures for targeted and controlled regulation of the immune system. This needs an interdisciplinary knowledge on materials design, precise synthesis, novel techniques in exploring the events on the biointerface between materials and immune cells, which definitely needs a lot more input and attentions to be paid on. As a result, this collection aims to collect more discussions and opinions, as well as new progress in this specific research field, and paves a better understanding and outcomes in the next 10 years. 🔑 Keywords: #Immunology, #Materials, Immune #homeostasis, #Biointerface 📅 Submission deadline: March 01, 2025 💲 APC: No article processing charge 🔗 Link to get more details: https://lnkd.in/gv4iXSsf

📢 New Online special issue: Immuno-Materials: at the interdisciplinary of immunology and materials is open for submissions now!! Welcome join us and discuss this topic! 📰 Edited by Dr. Wantong Song 🎯 A fundamental basis underlying immuno-materials is the understanding the basic process of how the immune cells recognize the pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) through the pattern recognition receptors (PRRs), and thus developing materials with patterned structures for targeted and controlled regulation of the immune system. This needs an interdisciplinary knowledge on materials design, precise synthesis, novel techniques in exploring the events on the biointerface between materials and immune cells, which definitely needs a lot more input and attentions to be paid on. As a result, this collection aims to collect more discussions and opinions, as well as new progress in this specific research field, and paves a better understanding and outcomes in the next 10 years. 🔑 Keywords: #Immunology, #Materials, Immune #homeostasis, #Biointerface 📅 Submission deadline: March 01, 2025 💲 APC: No article processing charge 🔗 Link to get more details: https://lnkd.in/gcb2AMex

👨🏫 Prof. Carsten Carlberg, WELCOME2 ERA Chair, was a speaker at the Joint International Symposium which took place on May 8-10 in Homburg/Saar, Germany. ✅ Carsten gave a lecture on "Vitamin D Signaling in Vivo: Focus on Human Immune Cells" during the session on "Molecular Biology of Vitamin D (I) - New Insights in Vitamin D Signaling." 💊 🔗 #welcome2nutrigenomics 👨⚕️ 👩🔬 The symposium provided a platform for scientists and clinicians to share and discuss the latest research findings and concepts related to #vitaminD. #nutrigenomics #epigenetics #conference #science #molecularbiology #invivo #immunology

👩🔬 Spotlight on Giuseppina Arbore, researcher at Libera Università Vita-Salute San Raffaele. The immunology topic she believes should have more attention is personalized immunotherapy, for cancer, autoimmune diseases, or other immune-related disorders. "For me, it is fascinating to study how the immune system can be educated and equipped with tailored weapons to fight diseases. With the continuous technological improvements and reduction in the cost of high-throughput technologies, we can investigate the diversity and plasticity of our immune system for precision medicine." #WomenInScience #WomenInImmunology European Federation of Immunological Societies Swiss Young Immunologists Society (SYIS) Young Scandinavian Society for Immunology Hellenic Society of Immunology Young Immunologists group (HSΙ-YI) French Club of Young Immunologists DGFI Young Immunologists SIICA International Union of Immunological Societies (IUIS) IUIS Junior Community yBIS - Young Belgian Immunological Society SFI Société Française d'Immunologie Deutsche Gesellschaft für Immunologie (DGfI) e.V. British Society for Immunology

In this engaging episode we explore the intriguing world of immunology with our guest Liliana Moura Massis, a leading Scientist in autoimmune diseases. Liliana recounts her inspiring journey from Brazil to Silicon Valley, facing challenges and seizing opportunities in the biomedical sciences. She reflects on the brain drain from Brazil, offers advice to emerging scientists, and discusses her transition from academia to industry, highlighting the differences and her innovative approach to immunology research. The episode also covers the future of autoimmune and inflammatory disease treatment, the promise of personalized medicine through technological advancements, and lessons from the Typhoid Mary story for public health. This episode is a compelling listen for anyone interested in the confluence of technology, health, and science, showcasing Liliana's remarkable journey and her visionary outlook on the future of healthcare. Check out, subscribe to our channel & share with your friends: https://lnkd.in/dhH5KzMD Maria Athayde | Eduardo Iha | Andre Chaves | RSTcom Comunicação Estratégica #FutureHacker #Immunology #BiomedicalScience #SiliconValley #AcademiaToIndustry #AutoimmuneDiseases #PersonalizedMedicine #PublicHealth #ScienceCareer #TechnologyInHealthcare #womeninscience #womeninstem

How rewarding is a career in science? Just ask Wistar research fellow, Dr. Gauri Mirji: "What could be better than finding answers to the biggest health challenges facing people today?" From grade school to grad school, Dr. Mirji has been driven by her fundamental curiosity, which she continues to explore at Wistar in her investigations of the human immune system. Read our story to learn more about what a day in the life of a research fellow is really like: https://bit.ly/4fu5Wfs #research #sciencecareers #womeninscience #immunology

💥 #CiteScore2023 Released! 🚀Exploration of Immunology is thrilled to announce that we receive our CiteScore 2023 with 1. 💐 The Citescore is a measure of the journal's impact and relevance in the scientific community, reflecting the average number of citations received per document published. Achieving a score of 1 highlights the growing influence and importance of the research we publish in advancing the field of immunology. #freepublication #immunology #scopus #ExplorationOfImmunology 💡 EI provides the following benefits for all contributors. Welcome your participation! ✅ APC Waivers: The journal does not charge APC from authors before March 31, 2026, during which time the APC is wholly financed by Open Exploration. ✅ Database indexing: #Scopus #Googlescholar #DOAJ, etc. ✅ Appealing offers: Highly Cited Paper Award (300-100 USD); Conference Promotion... 🔗 Submission link: https://lnkd.in/dxEwdZ9S ➡ Contact us at eijournal@explorationpub.com ➡ Scopus Page of EI: https://lnkd.in/dr6T_2VW

Bio-protocol's latest issue is now live! 🎉https://lnkd.in/gYXdeH-M A collection of useful protocols related to #cancerbiology, #cellbiology, #environmentalscience, #immunology, #microbiology, #molecularbiology and #plantscience is just a click away! Do you have a protocol that can contribute to scientific clarity and reproducibility? Explore publishing with Bio-protocol at https://lnkd.in/gR3QGYz6. #openaccess #reproducibility #lifesciences #research

What an incredible experience attending Immunotherapeutics 2024! The insights shared over these past three days have truly been transformative. 🙌✨ The diversity of topics—from AI in personalized medicine to the engineering of immune cells for better cancer treatment—showcased how far we’ve come and what lies ahead. A few standout moments: - Prof. Antonio Facchiano: “M as in Miconazole, Mitochondria, Melanoma” 🧬 - Prof. George Hajishengallis: Clonal hematopoiesis and its link to chronic disease 🧠 - Dr. Minna Kohler: The role of POCUS in diagnosing rheumatic autoimmune diseases 🩺 - Dr. Kristin Anderson: Engineering T-cells to overcome immune suppression in solid tumors 🦠 - Prof. Hamid Shokoohi, MD, MPH, FACEP: AI-powered ultrasound for managing Giant Cell Arteritis 🤖 - Dr. Konstantinos Tselios: CAR-cell therapies and their potential in autoimmunity 🔬 - Prof. Sheila K. Singh: Targeting glioblastoma with ROBO1 CAR-T cells 🎯 - Dr. Tayab Waseem MD PhD: The promise of AI for truly personalized medicine 🖥️ - Dr. Andrew Coveler: Recent developments in immunotherapy for GI cancers 🩹 This Congress wasn’t just about breakthroughs—it was a reminder of the collaborative spirit driving innovation. Each speaker pushed the boundaries, offering new hope for patients and more targeted therapies. What did you find most compelling at the event? Let’s dive into the future of immunotherapy! 🌍 #Immunotherapy #AIInMedicine #PersonalizedCare #EUSTM 🔗 https://lnkd.in/ddJKreB8

I am pleased to announce our newest paper "Response to Fingolimod in Multiple Sclerosis patients is associated with a a differential transcriptomic regulation" has been published in the International Journal of Molecular Sciences (MDPI) and is now accessible online. You can download it using this link: https://lnkd.in/dCMsX6EX #multiplesclerosis #research #science #rnaseq #immunology #researchpaper #neuroinflammation